89 related articles for article (PubMed ID: 9891527)
21. [Atypical endometrial hyperplasia. Prognosis and course].
Jensen HH; Hussain SF; Pedersen PH; Andreasson B
Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
[TBL] [Abstract][Full Text] [Related]
22. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of endometrial carcinoma after hysterectomy for atypical hyperplasia or FIGO stage IA carcinoma diagnosed on endometrial biopsy or endometrial resection].
Ploteau S; Squifflet JL; Berlière M; Marbaix E; Donnez J
Bull Cancer; 2008 May; 95(5):556-62. PubMed ID: 18541521
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric S-phase fraction contributes to diagnosis of diploid malignant salivary gland tumours.
Driemel O; Kraft K; Hemmer J
Int J Oral Maxillofac Surg; 2006 Oct; 35(10):947-50. PubMed ID: 16829041
[TBL] [Abstract][Full Text] [Related]
25. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
26. Endometrial brush biopsy. An accurate outpatient method of detecting endometrial malignancy.
Wu HH; Casto BD; Elsheikh TM
J Reprod Med; 2003 Jan; 48(1):41-5. PubMed ID: 12611094
[TBL] [Abstract][Full Text] [Related]
27. [Cytological findings on endometrial carcinoma and endometrial hyperplasia].
Nagai S; Sawada T
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2283-90. PubMed ID: 6663136
[TBL] [Abstract][Full Text] [Related]
28. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
[TBL] [Abstract][Full Text] [Related]
29. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
Lindahl B; Alm P
Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
[TBL] [Abstract][Full Text] [Related]
31. [Flow-cytometric study of aneuploidy and proliferative activity of endometrial cancer cells as indicators of tumor aggressiveness].
Bychkova NV; Meshkova IE; Pozharisskiĭ KM
Vopr Onkol; 1996; 42(2):57-62. PubMed ID: 8815635
[TBL] [Abstract][Full Text] [Related]
32. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
33. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
34. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
37. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
38. DNA analysis of laryngeal carcinoma cells by flow cytometry: the histoclinical factors and their significance.
Dobroś W; Lackowska B; Ryś J; Niezabitowski A; Stanisz-Wallis K; Olszewski E; Modrzejewski M
J Otolaryngol; 2000 Dec; 29(6):371-6. PubMed ID: 11770146
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]